Nigeria’s fight against HIV and AIDS may be approaching a turning point with the introduction of Lenacapavir, a long-acting injectable drug that experts say could greatly reduce new infections.

Please provide your email address to receive an email when new articles are posted on . The introduction of long-acting injectable cabotegravir PrEP in sub-Saharan Africa could result in fewer future ...

Through the Tanzania Medicines and Medical Devices Authority (TMDA), the drug has been officially registered in the country, ...

Salako revealed that about 52,000 doses of the injectable drug have already been secured to support the initial phase of implementation. The Nigerian government has announced plans to roll out a new ...

Background: Prevention programs often promote HIV testing as one possible strategy of combating the spread of the disease. Objective: To examine levels of HIV testing practices among a large sample of ...

In a landmark move to strengthen the fight against HIV/AIDS, the Federal Government has introduced Lenacapavir, a long-acting ...

The federal government has commenced the rollout of a new long-acting injectable drug (lenacapavir) for the prevention of HIV ...

The director-general of the National Agency for the Control of AIDS (NACA), Temitope Ilori, has clarified that the newly ...

Sustaining the achievements of the past two decades of global HIV programs and reaching the goal of ending HIV/AIDS as a public health threat by 2030 depend on dramatically reducing new infections.

From Scholastica Hir, Makurdi‎‎A Non Governmental Organization, Lawyers Alert has hailed the Federal Government, the National Agency for the Control of AIDS (NACA), and the National HIV, Viral ...